Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

Similar articles for PubMed (Select 9600986)

1.

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL.

Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53.

2.

Amyloid beta-derived diffusible ligands (ADDLs) induce abnormal expression of insulin receptors in rat hippocampal neurons.

Liu X, Teng Z, Cui C, Wang R, Liu M, Zhang Y.

J Mol Neurosci. 2014 Jan;52(1):124-30. doi: 10.1007/s12031-013-0216-0. Epub 2014 Jan 10.

PMID:
24402880
3.

Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.

Milton NG, Chilumuri A, Rocha-Ferreira E, Nercessian AN, Ashioti M.

ACS Chem Neurosci. 2012 Sep 19;3(9):706-19. Epub 2012 May 30.

4.

Fyn kinases play a critical role in neuronal apoptosis induced by oxygen and glucose deprivation or amyloid-β peptide treatment.

Du CP, Tan R, Hou XY.

CNS Neurosci Ther. 2012 Sep;18(9):754-61. doi: 10.1111/j.1755-5949.2012.00357.x. Epub 2012 Jun 18.

PMID:
22709448
5.

Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.

Poduslo JF, Howell KG, Olson NC, Ramirez-Alvarado M, Kandimalla KK.

Biochemistry. 2012 May 15;51(19):3993-4003. doi: 10.1021/bi300275g. Epub 2012 May 7.

PMID:
22545812
6.

Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.

Hwang SH, Shin EJ, Shin TJ, Lee BH, Choi SH, Kang J, Kim HJ, Kwon SH, Jang CG, Lee JH, Kim HC, Nah SY.

J Alzheimers Dis. 2012;31(1):207-23. doi: 10.3233/JAD-2012-120439.

PMID:
22543851
7.

Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.

Scherzer-Attali R, Farfara D, Cooper I, Levin A, Ben-Romano T, Trudler D, Vientrov M, Shaltiel-Karyo R, Shalev DE, Segev-Amzaleg N, Gazit E, Segal D, Frenkel D.

Neurobiol Dis. 2012 Jun;46(3):663-72. doi: 10.1016/j.nbd.2012.03.005. Epub 2012 Mar 19.

PMID:
22449754
8.

Xylocoside G reduces amyloid-β induced neurotoxicity by inhibiting NF-κB signaling pathway in neuronal cells.

Yu Y, Zhou L, Sun M, Zhou T, Zhong K, Wang H, Liu Y, Liu X, Xiao R, Ge J, Tu P, Fan DS, Lan Y, Hui C, Chui D.

J Alzheimers Dis. 2012;30(2):263-75. doi: 10.3233/JAD-2012-110779.

PMID:
22430528
9.

Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model.

Krantic S, Isorce N, Mechawar N, Davoli MA, Vignault E, Albuquerque M, Chabot JG, Moyse E, Chauvin JP, Aubert I, McLaurin J, Quirion R.

J Alzheimers Dis. 2012;29(2):293-308. doi: 10.3233/JAD-2011-110830.

PMID:
22232004
10.

Hyperoside protects primary rat cortical neurons from neurotoxicity induced by amyloid β-protein via the PI3K/Akt/Bad/Bcl(XL)-regulated mitochondrial apoptotic pathway.

Zeng KW, Wang XM, Ko H, Kwon HC, Cha JW, Yang HO.

Eur J Pharmacol. 2011 Dec 15;672(1-3):45-55. doi: 10.1016/j.ejphar.2011.09.177. Epub 2011 Sep 29.

PMID:
21978835
11.

Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.

Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY, Connelly J, Zhang W.

Neurosci Bull. 2011 Aug;27(4):221-32. doi: 10.1007/s12264-011-1015-7.

PMID:
21788993
12.

Prevention of amyloid-beta oligomer-induced neuronal death by EGTA, estradiol, and endocytosis inhibitor.

Cižas P, Jekabsonė A, Borutaitė V, Morkūnienė R.

Medicina (Kaunas). 2011;47(2):107-12.

13.

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.

Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H.

Curr Pharm Des. 2011;17(25):2594-602. Review.

PMID:
21728980
14.

Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.

Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.

Behav Brain Res. 2011 Sep 23;222(2):342-50. doi: 10.1016/j.bbr.2011.03.072. Epub 2011 Apr 14.

PMID:
21513747
15.

Impaired neural transmission and synaptic plasticity in superior cervical ganglia from β-amyloid rat model of Alzheimer's disease.

Alzoubi KH, Alhaider IA, Tran TT, Mosely A, Alkadhi KK.

Curr Alzheimer Res. 2011 Jun;8(4):377-84.

PMID:
21453246
16.

The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity.

Ovchinnikova OY, Finder VH, Vodopivec I, Nitsch RM, Glockshuber R.

J Mol Biol. 2011 May 13;408(4):780-91. doi: 10.1016/j.jmb.2011.02.049. Epub 2011 Mar 21.

PMID:
21402079
17.

Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.

Rammes G, Hasenjäger A, Sroka-Saidi K, Deussing JM, Parsons CG.

Neuropharmacology. 2011 May;60(6):982-90. doi: 10.1016/j.neuropharm.2011.01.051. Epub 2011 Feb 12.

PMID:
21310164
18.

Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.

Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.

J Alzheimers Dis. 2011;23(2):335-47. doi: 10.3233/JAD-2010-101242.

PMID:
21116052
19.

N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.

Decker H, Jürgensen S, Adrover MF, Brito-Moreira J, Bomfim TR, Klein WL, Epstein AL, De Felice FG, Jerusalinsky D, Ferreira ST.

J Neurochem. 2010 Dec;115(6):1520-9. doi: 10.1111/j.1471-4159.2010.07058.x. Epub 2010 Nov 11.

PMID:
20950339
20.

[Involvement of beta-amyloid in the etiology of Alzheimer's disease].

Tomiyama T.

Brain Nerve. 2010 Jul;62(7):691-9. Review. Japanese.

PMID:
20675873
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk